| Literature DB >> 21765893 |
Mélanie Falord1, Ulrike Mäder, Aurélia Hiron, Michel Débarbouillé, Tarek Msadek.
Abstract
The GraS/GraR two-component system has been shown to control cationic antimicrobial peptide (CAMP) resistance in the major human pathogen Staphylococcus aureus. We demonstrated that graX, also involved in CAMP resistance and cotranscribed with graRS, encodes a regulatory cofactor of the GraSR signaling pathway, effectively constituting a three-component system. We identified a highly conserved ten base pair palindromic sequence (5' ACAAA TTTGT 3') located upstream from GraR-regulated genes (mprF and the dlt and vraFG operons), which we show to be essential for transcriptional regulation by GraR and induction in response to CAMPs, suggesting it is the likely GraR binding site. Genome-based predictions and transcriptome analysis revealed several novel GraR target genes. We also found that the GraSR TCS is required for growth of S. aureus at high temperatures and resistance to oxidative stress. The GraSR system has previously been shown to play a role in S. aureus pathogenesis and we have uncovered previously unsuspected links with the AgrCA peptide quorum-sensing system controlling virulence gene expression. We also show that the GraSR TCS controls stress reponse and cell wall metabolism signal transduction pathways, sharing an extensive overlap with the WalKR regulon. This is the first report showing a role for the GraSR TCS in high temperature and oxidative stress survival and linking this system to stress response, cell wall and pathogenesis control pathways.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21765893 PMCID: PMC3128592 DOI: 10.1371/journal.pone.0021323
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
GraX, GraS and GraR are required for colistin resistance.
| Strain | Relevant genotype | Colistin MIC (µg ml−1) |
| ST1120 | HG001 pMK4-Pprot | 700 |
| ST1117 | Δ | 100 |
| ST1116 | Δ | 700 |
| ST1070 | Δ | 300 |
Strains were grown at 37°C in TSB with decreasing colistin concentrations. Growth was followed by measuring absorbance at 600 nm using a microtiter plate reader and MICs were determined as the colistin concentration inhibiting strain growth after 12 h. Each experiment was repeated at least three times.
Figure 1The graXRS operon is transcribed from a σA promoter.
(A) The graXRS/vraFG locus of S. aureus HG001. (B) Primer extension analysis of graXRS mRNA was carried out using total RNA extracted from S. aureus strain HG001 during mid-exponential growth in TSB at 37°C. Primer extension experiments were performed using the graX-specific oligonucleotide MF63 (lane 1). The corresponding Sanger dideoxy chain termination sequencing reactions (GATC) were carried out on a PCR-generated DNA fragment fragment corresponding to the graX upstream region (MF62/MF63). The transcriptional start site is boxed. (C) Nucleotide sequence of the graXRS operon upstream region. Potential σA-type -35 and −10 sequences are boxed and the transcriptional start site is labelled +1.
Figure 2GraXSR do not control their own synthesis.
Expression of the graXRS operon was followed using a graX'-lacZ transcriptional fusion in S. aureus strains HG001, ST1036 (ΔgraRS) and ST1070 (ΔgraX). β-Galactosidase assays were performed as described in Materials and Methods and measured during mid-exponential growth at 37°C in TSB (grey bars) or after treatment with 200 µg ml−1 colistin for the HG001 strain (black bar). Means and standard deviations values are presented from at least three independent experiments.
Figure 3Identification of potential GraR-binding sites in the promoters of known GraR-regulated genes.
(A) Primer extension analysis of mprF, dltXABCD and vraFG transcripts was carried out using total RNA extracted from S. aureus strain HG001 treated with 200 µg ml−1 colistin during mid-exponential growth at 37°C in TSB, using specific oligonucleotides for mprF, dltX and vraF (lanes 1 to 3 respectively). The corresponding Sanger dideoxy chain termination sequencing reactions (GATC) were carried out on PCR-generated DNA fragments corresponding to the respective upstream regions (see Table 5). The transcriptional start sites are boxed. (B) Alignment of the potential GraR DNA-binding sites in the mprF, dltXABCD and vraFG promoter regions. The potential GraR-binding site is shaded and conserved nucleotides are shown in white. Potential −35 and −10 sequences are underlined and the transcriptional start sites are indicated in bold.
Oligonucleotides used in this study*.
| Name | Sequence | Description |
| MF9 |
|
|
| MF10 |
| |
| MF11 |
|
|
| MF12 |
| |
| MF35 |
|
|
| MF36 |
| |
| MF37 |
|
|
| MF38 |
| |
| MF62 |
|
|
| MF63 |
| |
| MF66 |
|
|
| MF67 |
| |
| MF69 |
|
|
| MF70 |
| |
| MF74 |
|
|
| MF75 |
| |
| MF77 |
|
|
| MF78 |
| |
| MF88 |
|
|
| MF89 |
|
|
| MF90 |
| |
| MF91 |
|
|
| MF95 |
|
|
| MF96 |
| |
| MF97 |
|
|
| MF98 |
| |
| MF118 |
|
|
| MF119 |
| |
| OSA161 |
| 16S intragenic region, qRT-PCR |
| OSA162 |
| |
| OAH131 |
|
|
| OAH132 |
|
|
*Added restriction site sequences are indicated in italics.
Figure 4GraSR-dependent gene expression requires GraX, colistin and the consensus binding site.
vraFG (A) and mprF (B) expression was followed using transcriptional lacZ fusions, with or without the upstream GraR operator sequence (vraF'-lacZ, mprF'-lacZ and ΔAvraF'-lacZ, ΔAmprF'-lacZ, respectively). The fusions were introduced in S. aureus strains HG001, ST1036 (ΔgraRS) and ST1070 (ΔgraX). Expression was measured during mid-exponential growth in TSB at 37°C (grey bars) or after treatment with 50 µg ml−1 colistin (black bars). β-Galactosidase assays were performed as described in Materials and Methods. Means and standard deviation values are presented from three independent experiments.
Figure 5Point mutations in the GraR-binding site prevent vraFG expression and colistin induction.
(A) Alignment of the DNA sequences used to construct the vraF2'-lacZ and vraF2*-lacZ fusions. Potential −35 and −10 sequences are underlined, the identified transcriptional start site is indicated in bold and the GraR-binding site is shaded. Point mutations introduced in the vraF2*-lacZ fusion are shown in white. (B) vraF2'-lacZ and vraF2*-lacZ fusion expression was measured in S. aureus HG001 (strains ST1168 and ST1169, respectively) during mid-exponential growth at 37°C in TSB (grey bars) or after treatment with 200 µg ml−1 colistin (black bars). β-Galactosidase assays were performed as described in Materials and Methods. Means and standard deviations values are presented from three independent experiments.
Identification of potential new GraR regulon members by in silico genome scanning.
| NCTC 8325 | Gene or operon | DNA strand | Sequence | Function |
|
|
| |||
| 00867 |
| + |
| Teichoic acid D-alanylation |
| 01359 |
| + |
| Lysylphosphatidylglycerol synthetase |
| 02751 |
| + |
| Para-nitrobenzyl esterase |
| 00667 |
| + |
| ABC transporter |
|
| ||||
| 00167 |
| − |
| Oligopeptide transporter ATP-binding protein |
| 02815 |
| − |
| Probable glucarate transporter |
| 00669 | + |
| Putative Pit family transporter | |
|
| ||||
| 00992 |
| + |
| Probable ATL autolysin transcription regulator |
| 02571 |
| + |
| Amidase |
| 00972 |
| + |
| Teichoic acid glycosylation |
|
| ||||
| 01818 |
| − |
| Alanine dehydrogenase |
| 01002 |
| − |
| Quinol oxidase AA3 subunit II |
| 00035 |
| + |
| Probable multidomain redox protein |
| 01907 |
| − |
| 2,5-didehydrogluconate reductase |
| 00882 | − |
| NADH dehydrogenase-like | |
|
| ||||
| 01637 |
| − |
| Probable competence protein |
| 02500 |
| − |
| 50S ribosomal protein L5 |
| 02257 |
| − |
| Atypical serine-aspartate rich ( |
| 00903 |
| + |
| Type-1 signal peptidase 1B |
| 00776 |
| + |
| Excinuclease |
| 01819 | + |
| Universal stress protein UspA-like | |
| 02816 | + |
| Similar to alkaline phosphatase | |
| 00991 |
| − |
| Probable acyltransferase |
|
| ||||
| 00034 | − |
| Conserved hypothetical protein | |
| 00146 | − |
| Probable transmembrane protein | |
| 00971 | − |
| Probable transmembrane protein | |
| 01242 | + |
| Conserved hypothetical protein | |
| 01851 | − |
| Hypothetical protein | |
| 02320 | − |
| Hypothetical protein |
Gene names correspond to the annotation of the S. aureus NCTC 8325 genome sequence [69]. Only the first gene is indicated for operons.
Positions of the inverted repeats of the potential GraR-binding sites are indicated for the given DNA strand with respect to the translation initiation codon.
Known and putative functions for each regulon member based on genome annotations are indicated. Based on these predictions, the potential regulon members were divided in six categories (antimicrobial resistance, transport, cell envelope modification, oxidoreduction processes, other functions and unknown function).
*Indicates genes known or predicted to be controlled by the WalKR TCS [44], [46].
Figure 6The GraR operator consensus is a perfect inverted repeat obtained by alignment of regulon gene upstream sequences.
The consensus sequence for the GraR-binding site was generated using the WebLogo tool (http://weblogo.berkeley.edu/) by alignment of the upstream sequences of the 29 potential regulon genes identified by in silico analysis (Table 2).
Expression profiling of the ΔgraRS mutant.
| Category/Gene name | Function/similarity | HG001/Δ |
| |
|
| ||||
| SAOUHSC_02611 | HP similar to lysostaphin resistance protein A | 3.7 | <1.0E–16 | |
| SAOUHSC_01359 |
| Phosphatidylglycerol lysyltransferase | 2.8 | <1.0E–16 |
| SAOUHSC_00867 | HP | 2.7 | <1.0E–16 | |
| SAOUHSC_00868 |
| HP | 2.0 | 1.04E–11 |
| SAOUHSC_00869 |
| D-alanine-D-alanyl carrier protein ligase | 2.3 | <1.0E–16 |
| SAOUHSC_00871 |
| D-alanine carrier protein | 2.0 | 1.78E–11 |
| SAOUHSC_00872 |
| D-alanine-activating enzyme/transfer protein | 2.1 | 1.38E–14 |
| SAOUHSC_02866 | HP similar to drug exporter of the RND superfamily | 2.1 | 8.93E–14 | |
| SAOUHSC_02629 | Putative EmrB/QacA family drug resistance transporter | 1.8 | 1.16E–09 | |
| SAOUHSC_02630 | HP similar to multidrug resistance protein A | 1.9 | 3.42E–10 | |
| SAOUHSC_01866 | HP similar to aminoglycoside resistance associated protein | 1.8 | 5.96E–10 | |
|
| ||||
| SAOUHSC_02516 | HP similar to major facilitator transporter permease | 3.6 | <1.0E–16 | |
| SAOUHSC_00060* | HP similar to Na-Pi cotransporter family protein | 2.5 | <1.0E–16 | |
| SAOUHSC_00136 | HP similar to ABC transporter ATP-binding protein | 2.5 | <1.0E–16 | |
| SAOUHSC_00137 | HP similar to sulfonate/nitrate/taurine transport system substrate-binding protein | 2.0 | 1.41E–12 | |
| SAOUHSC_00138 | HP similar to sulfonate/nitrate/taurine transport system permease | 2.2 | 7.11E–15 | |
| SAOUHSC_00367 | HP similar to proton/sodium-glutamate symporter | 2.2 | 1.55E–15 | |
| SAOUHSC_02698 | Putative amino acid ABC transporter permease | 2.1 | 3.60E–14 | |
| SAOUHSC_02773 | Putative aminobenzoyl-glutamate transporter | 2.1 | 2.86E–13 | |
| SAOUHSC_00669* | HP similar to Pit family transporter | 1.9 | 2.44E–10 | |
| SAOUHSC_02699 | Putative amino acid ABC transporter ATP-binding protein | 1.9 | 4.39E–12 | |
| SAOUHSC_02482 |
| Cobalt transporter ATP-binding subunit | 1.8 | 5.57E–09 |
| SAOUHSC_02733 | HP similar to amino acid permesae | 1.8 | 1.38E–09 | |
|
| ||||
| SAOUHSC_02576* | HP CHAP domain-containing protein | 18.2 | <1.0E–16 | |
| SAOUHSC_02855 | HP CHAP domain-containing protein | 15.6 | <1.0E–16 | |
| SAOUHSC_00427* |
| N-acetylmuramoyl-L-alanine amidase | 14.9 | <1.0E–16 |
| SAOUHSC_02571* |
| Secretory antigen SsaA precursor | 8.0 | <1.0E–16 |
| SAOUHSC_00671* | HP CHAP domain-containing protein | 5.8 | <1.0E–16 | |
| SAOUHSC_02333* |
| Transglycosylase | 4.9 | <1.0E–16 |
| SAOUHSC_00994* |
| Bifunctional autolysin | 4.0 | <1.0E–16 |
| SAOUHSC_02887* |
| Immunodominant antigen A, transglycosylase | 5.5 | <1.0E–16 |
| SAOUHSC_00256 | HP CHAP domain-containing protein | 2.3 | <1.0E–16 | |
| SAOUHSC_02883* | HP CHAP domain-containing protein | 2.2 | 3.11E–15 | |
| SAOUHSC_00974 |
| wall teichoic acid glycosylation | 1.8 | 1.17E–08 |
|
| ||||
| SAOUHSC_00999* |
| Quinol oxidase, subunit IV | 4.0 | <1.0E–16 |
| SAOUHSC_01000* |
| Cytochrome c oxidase subunit III | 3.5 | <1.0E–16 |
| SAOUHSC_01001* |
| Quinol oxidase subunit I | 4.3 | <1.0E–16 |
| SAOUHSC_01002* |
| Quinol oxidase AA3 subunit II | 6.9 | <1.0E–16 |
| SAOUHSC_01103 |
| Succinate dehydrogenase cytochrome b-558 subunit | 1.8 | 2.66E–15 |
| SAOUHSC_01104 |
| Succinate dehydrogenase flavoprotein subunit | 1.9 | 3.73E–11 |
| SAOUHSC_01105 |
| Succinate dehydrogenase iron-sulfur subunit | 1.8 | 1.99E–09 |
|
| ||||
| SAOUHSC_00634 |
| Putative ABC transporter substrate-binding protein | 3.9 | <1.0E–16 |
| SAOUHSC_00636 |
| Putative iron (chelated) ABC transporter permease | 4.3 | <1.0E-16 |
| SAOUHSC_00637 |
| Putative manganese/iron ABC transporter ATP-binding protein | 2.5 | <1.0E–16 |
| SAOUHSC_03045 |
| Cold shock protein CspB | 2.3 | <1.0E–16 |
| SAOUHSC_01730 |
| Sigma-B mediated bacterial general stress response protein | 2.1 | <1.0E–16 |
| SAOUHSC_00819 |
| Cold shock protein C | 1.9 | 1.18E–13 |
| SAOUHSC_01403 |
| Cold shock protein | 1.9 | 1.13E–10 |
|
| ||||
| SAOUHSC_02261 |
| Accessory gene regulator protein B | 21.6 | <1.0E–16 |
| SAOUHSC_02262 |
| Accessory gene regulator protein D | 21.0 | <1.0E–16 |
| SAOUHSC_02264 |
| Accessory gene regulator protein C | 9.3 | <1.0E–16 |
| SAOUHSC_02265 |
| Accessory gene regulator protein A | 4.2 | <1.0E–16 |
| SAOUHSC_02566 |
| Staphylococcal accessory regulator R | 3.4 | <1.0E–16 |
| SAOUHSC_00674 |
| Staphylococcal accessory regulator protein X | 3.1 | <1.0E–16 |
| SAOUHSC_00070 |
| Staphylococcal accessory regulator A-like | 2.7 | <1.0E–16 |
| SAOUHSC_00230 |
| Two-component sensor histidine kinase | 2.0 | 3.21E–12 |
| SAOUHSC_00231 |
| Two-component response regulator | 2.0 | 5.40E–12 |
| SAOUHSC_01891 |
| Arsenical resistance operon repressor | 1.8 | 5.60E–10 |
| SAOUHSC_02388 |
| Metal-dependent transcriptional regulator | 1.8 | 7.31E–09 |
|
| ||||
| SAOUHSC_01135 | HP SLUSH-like haemolytic protein | 44.6 | <1.0E–16 | |
| SAOUHSC_01136 | HP SLUSH-like haemolytic protein | 98.4 | <1.0E–16 | |
| SAOUHSC_02260 |
| Delta-haemolysin | 80.1 | <1.0E–16 |
| SAOUHSC_01110 | Putative fibrinogen-binding protein | 8.5 | <1.0E–16 | |
| SAOUHSC_00300 |
| Lipase precursor | 4.7 | <1.0E–16 |
| SAOUHSC_01953 |
| Lantibiotic epidermin precursor EpiA | 3.2 | <1.0E–16 |
| SAOUHSC_02163 |
| Beta-haemolysin | 2.8 | 5.10E–11 |
| SAOUHSC_02167 | HP Similar to complement inhibitor protein SCIN | 2.8 | <1.0E–16 | |
| SAOUHSC_01121 |
| Alpha-haemolysin | 2.5 | <1.0E–16 |
| SAOUHSC_02169 |
| Chemotaxis-inhibiting protein CHIPS | 2.4 | <1.0E–16 |
| SAOUHSC_02963 |
| Clumping factor ClfB | 2.3 | 2.22E–16 |
| SAOUHSC_01114 |
| Fibrinogen-binding protein | 1.9 | 4.59E–10 |
| SAOUHSC_02257 |
| Atypical serine-aspartate rich ( | 1.9 | 2.84E–10 |
| SAOUHSC_02706 |
| Immunoglobulin G-binding protein | 1.8 | 2.77E–09 |
Gene names correspond to the annotation of the S. aureus NCTC 8325 genome sequence [69].
HP: hypothetical protein.
Fold-change of selected positively regulated genes determined as the ratio of the signal values between strain HG001 and the ΔgraRS mutant. * Indicates genes known or predicted to be controlled by the WalKR TCS [44], [46].
Figure 7Correlation between microarray and qRT-PCR experiments for expression of GraSR-dependent genes.
The expression levels of qoxA, ssaA, SAOUHSC_00669 and agrB genes were analyzed by qRT-PCR in the HG001 and ST1036 (ΔgraRS) strains. RNA samples were prepared from cultures during mid exponential growth after treatment with 50 µg ml−1 colistin. Comparative analysis (fold-change) of transcriptome analysis (black bars) and qRT-PCR experiments (grey bars) are shown. Means and standard deviation values for the qRT-PCR data are presented from at least three independent experiments.
Figure 8GraXSR are involved in oxidative stress resistance.
The effect of 40 mM paraquat was analyzed on HG001 (•, ○), ST1036 (▪, □; ΔgraRS), ST1070 (▴, ▵; ΔgraX) strains grown in TSB at 37°C, and diluted to a final OD 600 nm of 0.025. Growth was followed at 600 nm using a microtiter plate reader in the presence (closed symbols) or absence (open symbols) of 40 mM paraquat (methylviologen). A representative curve of three independent experiments is shown for each strain.
Figure 9GraSR are required for growth of Staphylococcus aureus at high temperature.
The effect of high temperature was tested on growth of S. aureus strains ST1120 (HG001 pMK4-Pprot), ST1117 (ΔgraRS pMK4-Pprot) and the complemented ΔgraRS mutant, ΔgraRS-c (strain ST1116; ΔgraRS pMK4-Pprot-graR). Strains were grown at 37°C in TSB and diluted to an OD 600 nm of 0.2. Serial dilutions were then carried out and 10 µl of each dilution was spotted on TSA plates, and incubated at 37°C or 44°C for 48 h.
Bacterial strains and plasmids used in this study.
| Strain or plasmid | Relevant genotype or description | Source or construction |
|
| ||
|
| ||
| DH5α™ | F- [Φ80 (d | Invitrogen Life Technologies |
|
| ||
| RN4220 | Restriction deficient transformation recipient |
|
| HG001 | NCTC 8325 |
|
| ST1036 | Δ | pMAD |
| ST1039 |
| pSA14 |
| ST1040 | ΔA | pSA14ΔA |
| ST1041 | Δ | pSA14 |
| ST1052 | Δ | pSA14 |
| ST1070 | Δ | pMAD |
| ST1074 |
| pSA14 |
| ST1075 | Δ | pSA14 |
| ST1082 |
| pSA14 |
| ST1105 | Δ | pSA14 |
| ST1111 | ΔA | pSA14ΔA |
| ST1112 | Δ | pSA14 |
| ST1116 | Δ | pMK4-Pprot |
| ST1117 | Δ | pMK4-Pprot → ST1036 |
| ST1120 | pMK4-Pprot, Cmr | pMK4-Pprot → HG001 |
| ST1168 |
| pSA14 |
| ST1169 |
| pSA14 |
| ST1176 | Δ | pSA14 |
| ST1199 |
| pSA14 |
|
| ||
| pMAD | pE194 derivative with a thermosensitive origin of replication for deletion/replacement of genes in Gram-positive bacteria |
|
| pMAD | pMAD derivative allowing deletion of the | This study |
| pMAD | pMAD derivative allowing deletion of the | This study |
| pSA14 | pMK4 derivative carrying the promoterless | This study |
| pSA14 | pSA14 derivative carrying the intergenic region between | This study |
| pSA14ΔA | pSA14 derivative carrying the truncated intergenic region between | This study |
| pSA14 | pSA14 derivative carrying the | This study |
| pSA14ΔA | pSA14 derivative carrying the | This study |
| pSA14 | pSA14 derivative carrying the | This study |
| pSA14 | pSA14 derivative carrying the | This study |
| pSA14 | pSA14 derivative carrying the truncated | This study |
| pSA14 | pSA14 derivative carrying the |
|
| pMK4Pprot | pMK4 derivative carrying a constitutive Gram-positive promoter for gene complementation |
|
| pMK4-Pprot | pMK4-Pprot derivative carrying | This study |
Arrows indicate plasmid introduction by electroporation.